期刊文献+

我院抗感染药物临床应用总体情况分析 被引量:1

Analysis of Anti-infection Agents Application in General Hospital of PLA
下载PDF
导出
摘要 目的了解医院抗感染药物的应用情况。方法统计中国人民解放军总医院第二临床药局2004—2006年抗感染药物消耗金额排序前20位以及按类别进行汇总后消耗金额的排序。结果抗感染药物的消耗金额2004—2006年分别为1241.66,1206.23,1362.53万元,3年消耗金额位于前3位的为头孢菌素类、碳青霉烯类、青霉素类抗生素。结论该院抗感染药物的临床应用基本安全、有效、合理,但同时应注意避免滥用。 Objective To investigate and analyze the utilization status of antimicrobials in the hospital. Methods To conduct comprehensive study on the data of antibiotic drugs purchased by the Second Pharmacy in General Hospital of PLA from 2004 to 2006 by ranking of sum of money. Results The consumption of antimicrobials in 2003, 2004, 2005 was 12.416 6, 12.062 3, 13. 625 3 million yuan respectively. Cephalosporin, carbapenem, penicillins antibiotics were the top 3 kinds of antimicrobial agents. Conclusion The utilization of antibiotic drugs is basically reasonable, nevertheless, the attention should be paid to those broad-spectrum, strong effective and new antibiotic drugs with unreasonable utilization phenomenon.
作者 裴斐 杨亚青
出处 《中国药业》 CAS 2007年第15期38-39,共2页 China Pharmaceuticals
关键词 抗感染药物 分析 合理用药 antimicrobial analysis rational use of drug
  • 相关文献

参考文献3

二级参考文献31

  • 1Lawrence L E. Anti bacterial activity of BMS284756, a novel des - F(6) - quinolone, against Staphylococcus aureus stuains with topoisow, erase mutations [ J ]. J Antimicrob Chemther, 2001, 47 ( Suppl1):44.
  • 2Nagai K, Appelbaum P C, Davies T A, et al. Susceptibility to Telithromycin in 1,011 Streptococcus tryogenes Isolates from 10 Central and Eestem European Countries [ J ] .Antimicrob Agents Chemother,2002,46(2) : 546.
  • 3Nagai K, Appelbaum P C, Davies T A, et al. Susceptibility to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pnmanococci from 10 central and easten european countries [ J ]. Antimicrob Agents Chemother, 2002,46(2) :371.
  • 4Mitten M J, Meulbroek J, Nukkala M, et al. Efficacies of ABT - 773, a new ketolide, against experimental bacterial Infections [J].Antimicrob Agents Chemother,2001,45(9) : 2585.
  • 5Nilius A M,Bui MH, Almer L, et al. Comparative In vitro aerivity of ABT- 773, a novel antibacterial ketolide [ J ]. Antimicrob Agents Chemother,2001,45(7) : 2163.
  • 6Alexis D,Alain B.Novel fluoroketohdes: synthesis and antibacterial activity [J] .Drugs Future,2001,26(10) : 975.
  • 7Noviello S,Ianniello F,Esposito S. In vitro activity of LY - 333328 (oritavanein) against gram- positive aerobic Cocci and synergy with ciprofloxacin against Enterococci [J]. J Antimicrob chemother , 2001, 48(2) :283.
  • 8Anon.IB397 [J]. Drugs Future,2000,25(8):849.
  • 9Anon. IB397 [J]. Drugs Future,2001,26(8):796.
  • 10Anon. Daptomyein: cidecin, dapcin, LY146032 [J]. Drugs in R&D,2002,3(1) :33.

共引文献24

同被引文献19

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部